| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |